What are the diagnostic criteria for syndrome of inappropriate antidiuretic hormone secretion (SIADH)?

Diagnostic Criteria for SIADH

SIADH is diagnosed when five cardinal criteria are simultaneously met: hypotonic hyponatremia (serum sodium <134 mEq/L), plasma osmolality <275 mosm/kg, inappropriately concentrated urine (osmolality >500 mosm/kg), urinary sodium >20 mEq/L, and clinical euvolemia in the absence of hypothyroidism, adrenal insufficiency, or volume depletion. 1

Essential Laboratory Criteria

Serum and plasma measurements:

• Serum sodium <134-135 mEq/L with simultaneous plasma osmolality <275 mosm/kg 1, 2
• This combination confirms true hypotonic hyponatremia and excludes pseudohyponatremia from hyperglycemia or hyperlipidemia 2

Urine studies:

• Urine osmolality >100 mosm/kg (typically >500 mosm/kg) despite low plasma osmolality 1, 2
• Urine sodium concentration >20-40 mEq/L, indicating continued natriuresis despite hyponatremia 1, 2
• The concentrated urine with high sodium content results from persistent or elevated plasma arginine vasopressin (AVP) despite hyponatremia and low plasma osmolality, leading to water retention and physiologic natriuresis where fluid balance is maintained at the expense of plasma sodium 1

Clinical Assessment Requirements

Volume status determination is paramount:

• Clinical euvolemia must be present—no orthostatic hypotension, no tachycardia, normal skin turgor, moist mucous membranes 1, 2
• Absence of edema, ascites, or jugular venous distention 1, 2
• Physical examination alone has poor accuracy (sensitivity 41.1%, specificity 80%) for volume assessment 1
• In neurosurgical patients, central venous pressure (CVP) 6-10 cm H₂O confirms euvolemia, distinguishing SIADH from cerebral salt wasting (CVP <6 cm H₂O) 1

Mandatory Exclusion Criteria

Normal organ function must be confirmed:

• Normal renal function: serum creatinine within normal limits 1, 2
• Normal thyroid function: TSH within normal range to exclude hypothyroidism 1, 2
• Normal adrenal function: morning cortisol >18-20 µg/dL or normal ACTH stimulation test to exclude adrenal insufficiency 1, 2
• Absence of volume depletion or diuretic use 1, 2

Supportive Diagnostic Markers

Additional laboratory findings:

• Serum uric acid <4 mg/dL has a positive predictive value of 73-100% for SIADH 1, 2
• However, low uric acid can also occur in cerebral salt wasting, limiting specificity 1
• Plasma AVP measurement is not required for diagnosis and does not alter management 2

Critical Diagnostic Algorithm

Step 1: Confirm hypotonic hyponatremia

• Measure serum sodium, plasma osmolality, and serum glucose simultaneously 2
• Adjust sodium for hyperglycemia: add 1.6 mEq/L to sodium for each 100 mg/dL glucose >100 mg/dL 3

Step 2: Assess urine concentration

• Obtain urine osmolality and urine sodium simultaneously with serum studies 2
• Urine osmolality >100 mosm/kg (typically >500 mosm/kg) confirms inappropriate concentration 1, 2
• Urine sodium >20-40 mEq/L confirms continued natriuresis 1, 2

Step 3: Determine volume status

• Assess for signs of hypovolemia: orthostatic hypotension, dry mucous membranes, decreased skin turgor 1, 2
• Assess for signs of hypervolemia: peripheral edema, ascites, jugular venous distention 1, 2
• In neurosurgical patients, measure CVP when available (SIADH: 6-10 cm H₂O; CSW: <6 cm H₂O) 1

Step 4: Exclude alternative diagnoses

• Check TSH to rule out hypothyroidism 1, 2
• Check morning cortisol or perform ACTH stimulation test to exclude adrenal insufficiency 1, 2
• Review medication list for SIADH-inducing drugs: SSRIs, carbamazepine, oxcarbazepine, NSAIDs, opioids, chemotherapy agents (cisplatin, vincristine, cyclophosphamide) 1, 2

Common Diagnostic Pitfalls

Confusing SIADH with cerebral salt wasting (CSW):

• SIADH: euvolemic, CVP 6-10 cm H₂O, requires fluid restriction 1, 2
• CSW: hypovolemic, CVP <6 cm H₂O, requires volume and sodium replacement 1, 2
• Using fluid restriction in CSW worsens outcomes and can precipitate cerebral ischemia 1
• In neurosurgical patients (subarachnoid hemorrhage, head trauma), CSW is more common than SIADH 1

Failing to obtain simultaneous measurements:

• Serum and urine studies must be collected simultaneously before initiating therapy 2
• Delayed or sequential testing can lead to misdiagnosis 2

Relying solely on physical examination:

• Physical examination alone is unreliable for volume status determination 1
• Laboratory parameters and CVP (when available) should guide assessment 1, 2

Ordering unnecessary tests:

• Plasma ADH levels add no clinical value and delay diagnosis 2
• Natriuretic peptide levels are not supported by evidence 1

Common Etiologies to Consider

Malignancy:

• Small cell lung cancer is the most common malignant cause, occurring in 1-5% of cases 2, 4
• SIADH occurs in 15% of small cell lung cancer patients 4

CNS disorders:

• Meningitis, encephalitis, subarachnoid hemorrhage, head trauma, space-occupying lesions 2, 5
• These conditions disrupt hypothalamic-pituitary function 2

Medications:

• High-risk drugs include SSRIs, carbamazepine, oxcarbazepine, NSAIs, opioids, chemotherapy agents (cisplatin, vincristine, cyclophosphamide, melphalan) 2, 4

Pulmonary diseases:

• Pneumonia, tuberculosis, positive pressure ventilation 4

Postoperative state:

• Inappropriate infusion of hypotonic fluids remains a common cause 6
• Nonosmotic stimuli (pain, nausea, stress) override normal osmotic regulation and cause AVP excess 2